Written Question · S2W-07356 · Session 2
Further to the answer to question S2W-7014 by Malcolm Chisholm on 30 March 2004, whether the Chief Scientist Office has received any propos…
The question
To ask the Scottish Executive, further to the answer to question S2W-7014 by Malcolm Chisholm on 30 March 2004, whether the Chief Scientist Office has received any proposals for research into attention deficit hyperkinetic disorder and drugs misuse and, if so, what the reasons are for the research not being supported.
The answer
In the recent past, the ChiefScientist Office (CSO) has received two research proposals on attention deficithyperkinetic disorder (ADHD). The first proposal, relating to the acute and chroniceffects of the psychostimulent drug methylphenidate (Ritalin) in girls with ADHD,was rejected by the Biomedical and Therapeutic Research Committee in June 2003 asit did not meet the required quality threshold for funding.
The second proposal has now beenallocated support through CSO’s NHS Mental Health Programme Support Grant funding.The proposed research will investigate whether chronic treatment with methylphenidatein boys with ADHD leads to tolerance or sensitisation, two processes associatedwith the development of substance misuse problems. Work on this project will commencein the near future.
The second proposal has now beenallocated support through CSO’s NHS Mental Health Programme Support Grant funding.The proposed research will investigate whether chronic treatment with methylphenidatein boys with ADHD leads to tolerance or sensitisation, two processes associatedwith the development of substance misuse problems. Work on this project will commencein the near future.
In the Official Report
No contribution in the Official Report cites S2W-07356 by reference.